StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Ruchit Jain, Motilal Oswal

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byRuchit Jain, Motilal OswalHorizon: 1–3 months30 Mar 2026via ET Now

Entry₹2,131.7Inferred
Target₹2,300
Total upside +7.90% (call closed)
Stop loss₹2,030-4.77% risk
Exit₹2,0302 Apr 2026, 12:04 pm
Stop-loss hit-4.77%
Follow Ruchit Jain for new calls(42% target hit, 26 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 2 active Short-term calls on GLENMARKSee 43 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 22 Oct, 5:36 pm IST
1 supporting1 opposing
Supports the BUY call (1)

2 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·2 Sept · 7mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·3 Feb · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Ruchit Jain, Motilal Oswal

Every call and its outcome